Literature DB >> 9517387

Inhibitory action of insulin-sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guinea-pig.

Y Nakamura1, Y Ohya, U Onaka, K Fujii, I Abe, M Fujishima.   

Abstract

1. The actions of troglitazone, pioglitazone, metformin and bezafibrate, agents that improve insulin-resistance, on voltage-dependent Ca2+ channels in arterial smooth muscle cells were examined by use of the conventional and nystatin-perforated whole-cell clamp methods. Single cells were freshly isolated from resistance mesenteric arteries of guinea-pigs. The actions of these agents on 77 mM K+-induced contraction of the isolated arteries were also examined with the use of isometric tension recording. 2. The thiazolidinedione derivatives, troglitazone and pioglitazone, inhibited whole-cell Ca2+ currents in a dose-dependent manner with dissociation constants of 3.0 microM and 44.9 microM and Hill coefficients of 0.61 and 0.68, respectively. These two agents inhibited the 77 mM K+-induced contraction with similar potencies as those inhibiting the Ca2+ currents. Metformin and bezafibrate had no apparent effects on the Ca2+ current or high K+-induced contraction. 3. The inhibitory action of troglitazone on Ca2+ currents was not affected by the command potential, the holding potential, or the stimulation frequency, suggesting that its mode of the action differs from that of known organic Ca2+ channel antagonists. 4. The inhibitory action of troglitazone on Ca2+ currents was not affected by the addition of insulin to, or the removal of glucose from, the solutions. 5. In conclusion, the thiazolidinedione derivatives directly inhibited the voltage-dependent Ca2+ channels in a different manner from that of organic Ca2+ channel antagonists. This inhibitory action on Ca2+ channels was not a common feature of insulin-sensitizing agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517387      PMCID: PMC1565220          DOI: 10.1038/sj.bjp.0701669

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin.

Authors:  J E Tooke; L M Elston; K M Gooding; C I Ball; D M Mawson; J Piper; R Sriraman; R Urquhart; A C Shore
Journal:  Diabetologia       Date:  2006-03-01       Impact factor: 10.122

2.  Sodium-potassium pump current in smooth muscle cells from mesenteric resistance arteries of the guinea-pig.

Authors:  Y Nakamura; Y Ohya; I Abe; M Fujishima
Journal:  J Physiol       Date:  1999-08-15       Impact factor: 5.182

3.  Troglitazone improves recovery of left ventricular function after regional ischemia in pigs.

Authors:  P Zhu; L Lu; Y Xu; G G Schwartz
Journal:  Circulation       Date:  2000-03-14       Impact factor: 29.690

4.  Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution.

Authors:  L C Pickavance; M Tadayyon; P S Widdowson; R E Buckingham; J P Wilding
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

5.  Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs.

Authors:  Ya Xu; Li Lu; Clifford Greyson; Jenny Lee; Michael Gen; Koichiro Kinugawa; Carlin S Long; Gregory G Schwartz
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

6.  Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.

Authors:  M Asano; T Nakajima; K Iwasawa; T Morita; F Nakamura; H Imuta; K Chisaki; N Yamada; M Omata; Y Okuda
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 7.  PPAR gamma and human metabolic disease.

Authors:  Robert K Semple; V Krishna K Chatterjee; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

8.  Enhanced inhibition of L-type calcium currents by troglitazone in streptozotocin-induced diabetic rat cardiac ventricular myocytes.

Authors:  Masaya Arikawa; Naohiko Takahashi; Tetsuya Kira; Masahide Hara; Tetsunori Saikawa; Toshiie Sakata
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

9.  Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension.

Authors:  Carmen M Halabi; Andreas M Beyer; Willem J de Lange; Henry L Keen; Gary L Baumbach; Frank M Faraci; Curt D Sigmund
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

10.  Effects of chronic PPAR-agonist treatment on cardiac structure and function, blood pressure, and kidney in healthy sprague-dawley rats.

Authors:  Eileen R Blasi; Jonathan Heyen; Michelle Hemkens; Aileen McHarg; Carolyn M Ecelbarger; Swasti Tiwari
Journal:  PPAR Res       Date:  2009-06-11       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.